Helen Chiehyu Wang, MD
Pediatrics · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Wang’s office at (408) 739-6000 to ask if they take your plan before you enroll.
Medicaid work
$315 in 2023
Medicaid paid $315 for 13 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 13 | $315 |
| 2023 | 13 | 1 | 13 | $315 |
| 2022 | 32 | 1 | 17 | $350 |
| 2021 | 125 | 2 | 28 | $838 |
| 2020 | 157 | 5 | 28 | $1,147 |
| 2019 | 230 | 3 | 24 | $5,664 |
| 2018 | 392 | 6 | 34 | $7,692 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 32 | $350 |
2021
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 42 | $838 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 83 | $0 |
2020
| Short return visit (20+ min) | 29 | $740 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 12 | $352 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 25 | $37 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 32 | $18 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 59 | $0 |
2019
| Short return visit (20+ min) | 184 | $4,347 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 27 | $1,227 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 19 | $90 |
2018
| Short return visit (20+ min) | 235 | $4,944 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 97 | $2,274 |
| Developmental screening | 17 | $356 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 17 | $63 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 14 | $27 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 12 | $27 |
Money from drug and device companies
$143 in 2025
| 2025 | 2 | 2 | None | $143 |
| 2024 | 1 | 1 | None | $28 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $122 | 1 payment
|
| Insulet | Omnipod | $21 | 1 payment
|
See all 2 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-25 | Airsupra | $122 |
| Insulet | Meals · 2025-01-14 | Omnipod | $21 |
See earlier years (2024)
2024: $28
| Ethicon US | Surgiflo Hemostatic Matrix | $28 | 1 payment
|
Professional record
- NPI
- 1437492667
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2013-04-06
- NPI last updated
- 2026-04-27
- NPI record certified
- 2026-04-27
This is when the NPI record was last certified, not a medical board exam.